These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25145532)

  • 1. Lack of negative interaction between use of β-blockers and statins on cardiovascular outcomes among patients with or at risk for atherothrombosis.
    Abtan J; Elbez Y; Bhatt DL; Steg PG
    J Am Coll Cardiol; 2014 Aug; 64(8):845-7. PubMed ID: 25145532
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anabolic effects of statin and beta-blocker on bone metabolism].
    Taguchi M; Takeuchi Y
    Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery.
    Noordzij PG; Poldermans D; Schouten O; Schreiner F; Feringa HH; Dunkelgrun M; Kertai MD; Boersma E
    Coron Artery Dis; 2007 Feb; 18(1):67-72. PubMed ID: 17172933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous pulmonary thromboembolism and atherothrombosis: need for a new approach.
    Aursulesei V; Roca IC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):724-32. PubMed ID: 25341292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of the cardiology patient with polyvascular disease: PRISMA study].
    Cournot M; Cambou JP; Ferrières J; Grenier O; Herrmann MA; Cantet C; Leizorovicz A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):841-8. PubMed ID: 15521475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.
    Joynt KE; Gattis WA; Hasselblad V; Fuzaylov SY; Serebruany VL; Gurbel PA; Gaulden LH; Felker GM; Whellan DJ; O'Connor CM
    Am J Cardiol; 2004 Mar; 93(6):783-5. PubMed ID: 15019895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction.
    Quinaglia e Silva JC; Munhoz DB; Morato TN; Gurgel A; Macedo AC; Sever P; Sposito AC;
    Am J Cardiol; 2009 Feb; 103(4):461-3. PubMed ID: 19195502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers and statins in non-cardiac surgery.
    Bolsin S; Colson M; Conroy M
    BMJ; 2007 Jun; 334(7607):1283-4. PubMed ID: 17585122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common cardiovascular medications in cancer therapeutics.
    Vaklavas C; Chatzizisis YS; Tsimberidou AM
    Pharmacol Ther; 2011 May; 130(2):177-90. PubMed ID: 21277894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
    Kitchlu A; Clemens K; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Manno M; Oliver MJ; Quinn RR; Suri RS; Wald R; Yan AT; Garg AX
    Nephrol Dial Transplant; 2012 Apr; 27(4):1591-8. PubMed ID: 21873621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statins: an intriguing nexus between osteoporosis and atherothrombosis].
    Pérez Jiménez F; Quesada Gómez JM
    Med Clin (Barc); 2001 May; 116(18):696-7. PubMed ID: 11412682
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart rate variability.
    Bilchick KC; Berger RD
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):691-4. PubMed ID: 16836727
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging therapies for atherosclerosis prevention and management.
    Chyu KY; Shah PK
    Cardiol Clin; 2011 Feb; 29(1):123-35. PubMed ID: 21257104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
    Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choosing the right medication for the right patient].
    Durand E; Kadri Z; Danchin N
    Rev Prat; 2005 Oct; 55(16):1805-11. PubMed ID: 16363431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].
    Pokrovskiĭ AV; Goloviuk AL
    Angiol Sosud Khir; 2010; 16(2):7-11. PubMed ID: 21032867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy in the perioperative period.
    Lander JS; Coplan NL
    Rev Cardiovasc Med; 2011; 12(1):30-7. PubMed ID: 21546886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.